We assessed the prognostic value of GPR158 in the four subtypes of GBM [4] and found significantly longer survival of GPR158high patients in the proneural and neural groups (Fig. 8e and Supplementary table 4), but not in the other two groups (Figs. 8g, h), and there is no influence of CCND1 expression on survival (Figs. 8j, k). The gene discussed is GPR158; the disease is glioblastoma.